immunotherapy
-
【Product for Licensing】T-cell engager (TCE), bispecific, trispecific, and multispecific products are available
If you are interested in similar assets, please contact DrugTimes BD Team at BD@drugtimes.cn asap. Many thanks!~
-
Exchanging a CAR-T therapy for 18% of the shares, the decision-making of Innovent Biologics
All comments are highly welcome!